OTC catalysts don't have to be amazing to cause a stock to run. Look at OWC, it ran to $3.23 on practically nothing. Oncolix has quite a bit more going for it and anything remotely positive from phase I trials can send it parabolic like what happened to Innovation Pharma, which ran to $4.93. Even with a fully diluted OS from everything contained in the S1, Oncolix still has the potential to make a comparable run to those two companies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.